San Francisco startup Framework Therapeutics is likewise focusing on an oral, as soon as-every day GLP-one drug termed GSBR-1290—the drug surpassed Wall Road’s expectations in June any time a mid-phase examine confirmed regular weight loss of about six% and it programs to start out A